Related Experiment Video
Updated: Aug 17, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Dual role of Nrf2 in cancer: molecular mechanisms, cellular functions and therapeutic interventions
M Poornashree1, Hitesh Kumar1, Ramkishan Ajmeer2
1Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, 570015, Mysuru, India.
Background:
Nrf2 regulates oxidative stress, which is essential for cellular function. Fundamental initiation of Nrf2 in many malignancies increases prosurvival genes & endorses tumour cell propagation via metabolic reprogramming, suppression of tumour programmed cell death, & increased cancer stem cell self-renewal potential. More specifically, Nrf2 has been associated with cancer cell chemoresistance, radioresistance & inflammation-induced carcinogenesis. METHODS AND RESULTS: Many Nrf2 inhibitors have been revealed for tumour treatment and targeting Nrf2 could be an effective cancer therapeutic method. Before spreading, cancer cells adapt to their surroundings. Cancer cells usually have mutations in tumor suppressor genes. In a variety of malignancies, somatic mutations & other anomalies in the Nrf2 genes, as well as renowned cancer suppressor genes including TP53, CDKN2A, PTEN & PIK3CA, have been found. In tumour cells, somatic mutations in the Nrf2 genes, as well as additional mechanisms that affect Nrf2 binding, and produce aberrant Nrf2 activation. Uncontrolled Nrf2 causes tumour cells to become resistant to antineoplastic drugs & reactive oxygen species (ROS), as well as guiding them toward metabolic reprogramming. CONCLUSIONS: As a result, Nrf2 has been studied as potential malignancy treatment target. We covered the pathways, mechanisms, and dual characteristics of Nrf2 in malignancy in this article. We also discussed how Nrf2 inhibitors are targeted against cancer in this review.
Insights
Nuclear factor erythroid 2-related factor 2 (Nrf2) plays a dual role in cancer, promoting tumor growth and resistance. Inhibiting Nrf2 shows promise as an effective cancer therapy by targeting these pro-tumorigenic functions.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Signaling
Background:
- Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates oxidative stress, crucial for cellular function.
- Aberrant Nrf2 activation in malignancies promotes tumor cell survival, proliferation, and resistance to therapy.
- Nrf2 is linked to chemoresistance, radioresistance, and inflammation-driven carcinogenesis.
Purpose of the Study:
- To review the multifaceted roles of Nrf2 in cancer development and progression.
- To explore the mechanisms underlying Nrf2's dual function in malignancies.
- To discuss the therapeutic potential of targeting Nrf2 in cancer treatment.
Main Methods:
- Literature review of studies investigating Nrf2 pathways in cancer.
- Analysis of genetic mutations and anomalies affecting Nrf2 activation in tumors.
- Examination of Nrf2's impact on cellular processes like metabolic reprogramming and apoptosis.
Main Results:
- Somatic mutations in Nrf2 and associated tumor suppressor genes (TP53, CDKN2A, PTEN, PIK3CA) are common in various cancers.
- Uncontrolled Nrf2 activation confers resistance to chemotherapy, radiotherapy, and reactive oxygen species (ROS).
- Nrf2 influences cancer stem cell self-renewal and metabolic reprogramming, aiding tumor adaptation and spread.
Conclusions:
- Nrf2 is a significant target for novel cancer therapeutic strategies.
- Understanding Nrf2's complex roles is key to developing effective Nrf2 inhibitors for cancer treatment.
- Targeting Nrf2 offers a promising approach to overcome cancer cell resistance and improve treatment outcomes.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Abnormal Proliferation